Telmisartan/Hydrochlorothiazide Liconsa 80 mg/25 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan/hydrochlorothiazide liconsa 80 mg/25 mg tablets

laboratorios liconsa, s.a. - telmisartan; hydrochlorothiazide - tablet - 80 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; telmisartan and diuretics

MIZART HCT 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mizart hct 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: meglumine; sodium hydroxide; mannitol; povidone; magnesium stearate; lactose monohydrate; purified water; sodium stearylfumarate; colour - mizart hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

MIZART HCT 80/12.5mg   telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mizart hct 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack

alphapharm pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; sodium hydroxide; mannitol; meglumine; sodium stearylfumarate; purified water; iron oxide red - mizart hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

MIZART HCT 40/12.5mg  telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mizart hct 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack

alphapharm pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: sodium hydroxide; mannitol; povidone; lactose monohydrate; meglumine; magnesium stearate; sodium stearylfumarate; purified water; iron oxide red - mizart hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

MICARDIS PLUS 80/25 telmisartan 80 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

micardis plus 80/25 telmisartan 80 mg and hydrochlorothiazide 25 mg tablet blister pack

boehringer ingelheim pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 25 mg - tablet, multilayer - excipient ingredients: maize starch; sorbitol; sodium hydroxide; iron oxide yellow; magnesium stearate; lactose monohydrate; microcrystalline cellulose; povidone; sodium starch glycollate type a; meglumine - micardis plus is indicated for the treatment of hypertension. treatment should not be intitiated with these combinations.

Telmisartan GH telmisartan 80mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan gh telmisartan 80mg tablets blister pack

generic health pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium hydroxide; mannitol; magnesium stearate; sodium stearylfumarate; povidone; meglumine - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Telmisartan GH telmisartan 40mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan gh telmisartan 40mg tablets blister pack

generic health pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: mannitol; meglumine; sodium hydroxide; povidone; sodium stearylfumarate; magnesium stearate - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

TELMISARTAN - HYDROCHLOROTHIAZIDE TEVA 80/25 mg/mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan - hydrochlorothiazide teva 80/25 mg/mg tablets

teva pharma b.v. - telmisartan, hydrochlorothiazide - tablets - 80/25 mg/mg - angiotensin ii antagonists and diuretics

TELMISARTAN - HYDROCHLOROTHIAZIDE TEVA 80/12.5 mg/mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan - hydrochlorothiazide teva 80/12.5 mg/mg tablets

teva pharma b.v. - telmisartan, hydrochlorothiazide - tablets - 80/12.5 mg/mg - angiotensin ii antagonists and diuretics